Skip to content
  • Home
  • Contact Us
  • Sitemap
  • Home
  • Contact Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 2, 2024

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »
Page1 Page2 Page3 … Page7
RECENT POSTS

Anaqua établit une nouvelle norme en matière de protection moderne des marques grâce à des solutions optimisées par l’IA

April 22, 2026

Anaqua établit une nouvelle norme en matière de protection moderne des marques grâce à des solutions optimisées par l’IA

April 22, 2026

Coventry en tête du Rapport 2025 des rachats de contrats d’assurance-vie

April 20, 2026

CGTN : Comment la Chine et l’Espagne renforcent leurs liens dans un contexte d’incertitude mondiale

April 17, 2026

Bitget lance le programme Broker Max Check avec jusqu’à 12 000 USDT pour les nouveaux courtiers

April 16, 2026

Ceres lance Ceres® Endura™ — une plateforme à oxyde solide révolutionnaire

April 16, 2026
ADVERTISEMENT
Copyright © 2026 Le Congo Tribune. All Rights Reserved.